2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Treatment Considerations, Drug Development, Biological Therapies, Transplantation, Non-Biological Therapies, Pharmacology, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Bleeding and Clotting, Hemophilia, Platelet Disorders, Thrombotic Disorders, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Study Population, Human, Adult, Animal Model
PAPER

4754 Stressed hepatic megakaryopoiesis increases thrombosis risk in severe anemic murine neonates

Arjun Surya Subrramanya, B.Tech, Juanitaa George Raj, B.Tech2, Hina Gaur3, Marie Amalie Balamurugan, MS4, Balamurugan Ramatchandirin, PhD5, Pranavi Prakash6, Sayma Azeem, PhD7, Yun Wei8, Elie Abu Jawdeh9, Danielle Callaway10, Krishnan MohanKumar, PhD11
1 University of Texas Southwestern Medical Center, Dallas, Texas, United States
2 University of Texas Southwestern Medical Center, Dallas, Texas, United States
3 University of Texas Southwestern Medical Center, Dallas, Texas, United States
4 University of Texas Southwestern Medical Center, Dallas, Texas, United States
5 Center for Pulmonology and Vascular Biology, UTSW, Dallas, Texas, United States, University of Texas Southwestern Medical Center, Dallas, Texas, United States
6 University of Nebraska Medical Center, Omaha, Nebraska, United States
7 University of Texas Southwestern Medical Center, Dallas, Texas, United States
8 5Harold C. Simmons Comprehensive Cancer Center, UTSW, Dallas, Texas, United States, University of Texas Southwestern Medical Center, Dallas, Texas, United States
9 University of Texas Southwestern Medical Center, Dallas, Texas, United States
10 Center for Pulmonology and Vascular Biology, UTSW, Dallas, Texas, United States, University of Texas Southwestern Medical Center, Dallas, Texas, United States
11 Center for Pulmonology and Vascular Biology, UTSW, Dallas, Texas, United States, University of Texas Southwestern Medical Center, Dallas, Texas, United States

Systemic inflammation (SI) and microvascular thrombosis are closely related and induced by infection in critically ill neonates. Using our existing neonatal murine model of phlebotomy-induced anemia (PIA), we recently identified a pattern of ‘leaky gut’ associated with endotoxin in the blood that leads to SI. It is well known that platelet activation and aggregation in microvasculature lead to thrombosis in response to bacterial products. However, the role of anemia-associated platelet dysfunction in microvascular thrombosis remains unknown. In this study, we identify an unrecognized gut-liver megakaryocyte (MK) axis in which anemia induces stress and pro-inflammatory hepatic MK production, thereby generating reactive and immature platelets (IPF) that promote microvascular thrombosis.

Histological analysis demonstrated increased presence of microthrombosis in the lungs of anemic mice, suggesting platelet-driven microvascular thrombi. Using Sysmex XN10V- Veterinary Hematology Analyzer, we found severely anemic murine pups (hematocrit 20-22%) developed thrombocytopenia accompanied by significantly increased mean platelet volume (7.87±0.30; p<0.001), platelet distribution width (6.22±0.32; p<0.001), platelet-large cell ratio (9.53±3.18; p<0.001), and IPF% (14.99±4.99; p<0.001), which indicated increased stress thrombopoiesis and release of larger IPF. Flow cytometry of blood using antibodies for CD41, CD62p, and thiazole orange (TO) showed an expansion of reactive IPF (CD41+CD62p+TO+) from 11.8% (control) to 36.8% (anemic; p<0.001), and of reactive mature platelets (CD41+CD62p+TO-) from 11.6% (control) to 44.5% (anemic; p<0.001). To investigate whether the bone marrow (BM) undergoes anemic stress and releases these significant numbers of platelets, we further performed similar flow analysis, including megakaryopoiesis, and assessed DNA-ploidy in BM cells from control and anemic mouse pups.  Surprisingly, there were no changes in the numbers of MK progenitors, and lower-ploidy MK with reduced cytoplasmic and nuclear size were noted during anemia. In addition, CD41+ flow-sorted cells from the BM of anemic mice display a pro-inflammatory phenotype with higher expression of toll-like receptor (TLR)-4, and RNA sequencing followed by pathway analysis indicates activation of non-canonical TLR4 signaling together with suppression of cytoskeletal and proplatelet formation pathways, consistent with dysfunctional platelet production.

To determine the functional contribution of TLR4 pathways, we used TLR4-/- mice with PIA. Flow analysis showed robust MK maturation and ploidy but did not rescue the increased IPF or pulmonary thrombosis, indicating that impaired BM thrombopoiesis alone does not account for the thrombo-inflammatory phenotype. To identify alternative extramedullary organs for IPF, we assessed the liver and spleen by flow cytometry for megakaryopoiesis, ploidy, reactivity, and RNA sequencing of liver-derived CD41+ cells. Surprisingly, hepatic CD41⁺ HSCs increased from 43% in control mice to 64% in anemic mice (p<0.001), while MK-erythroid progenitors increased from 22% in control mice to 38% in anemic mice (p<0.001), yet the spleen showed minimal to no compensatory hematopoiesis. Bulk RNA sequencing of the hepatic CD41⁺ cells demonstrated distinct organ-specific MK signaling in anemic murine neonates, with an inflammatory transcriptional program characterized by marked upregulation of platelet-formation transcripts, including triggered receptor expressed on myeloid cells-1 (trem1) (~50-fold), IL-1β (~22-fold), IFN-γ (~70-fold), TNF-α, and IL-12A, compared with anemic BM-CD41+ cells.

Based on our existing studies, restoring E-cadherin-associated intestinal homeostasis by inhibiting microRNA-let-7e-5p reduces bacterial translocation and lowers endotoxin levels in the liver. We administered a let-7e-5p microRNA inhibitor to PIA mice, and flow analysis showed a significant reduction in reactive platelets and pulmonary thrombosis, supporting a mechanistic gut–liver axis in hepatic MK production. Further testing of these MK and/or platelet abnormalities in adult mice with PIA demonstrated that this mechanism is unique to neonates. Collectively, these findings establish an unrecognized gut–liver MK axis in which neonatal anemia suppresses BM thrombopoiesis and promotes inflammatory hepatic MK generation, leading to trem1+ hyperreactive IPF that drives microvascular thrombosis, and identify trem1 as a promising therapeutic target.

Arjun Surya Subrramanya, B.Tech: No relevant conflicts of interest to declare.